News

« Back to Recent News

"The Role of Epipen (epinephrine) and Epipen Jr. (epinephrine) Auto-Injectors for Patients at Risk for Anaphylaxis"
Apr 18, 2013

Date & Time: April 18th, 2013, 6:30pm

Location: Sitar Indian Cuisine

Address: 420 Jordan Ln NW Huntsville, AL 35805 (256) 536-3360

Hosted By: Andrea Kilgore, Mylan Specialty L.P. and Shashi Kumr MD, aAPI

Message: Please register for this program today. 
  
3 WAYS TO REGISTER: 
  
1. RSVP thru the pingg e-mail you received. 
2. Contact Shashi Kumar at shashikumaram@yahoo.com 
3. Click the link below to register on our aAPI website. 
http://www.alabamaapi.org/calendar_detail.asp?id=5610  
 
Program Summary:
Anaphylaxis is a severe, life-threatening systemic allergic reaction that poses serious consequences for at-risk patients. Food is the most common trigger of anaphylaxis in children. Recent data estimate an 8% overall prevalence of food allergy among children in the United States.

It is critical to educate patients at risk for anaphylaxis on the importance of constant allergen avoidance, and to work with them on developing a comprehensive anaphylaxis action plan. Epinephrine auto-injector is one of the key components of an anaphylaxis action plan. However, carrying epinephrine auto-injector does not prevent patients from having an anaphylactic reaction; hence, patients must remain vigilant of their environment at all times. A key guideline recommends first-line treatment with epinephrine in all cases of anaphylaxis.

This program will utilize a case-based approach to help health care professionals proactively identify and assess at-risk patients and implement appropriate management strategies in the event of an anaphylactic emergency. Key diagnostic criteria associated with anaphylaxis will be reviewed and the continuum of anaphylaxis will be discussed. This program will review the rationale and role of epinephrine for the management of anaphylaxis while introducing EpiPen® and EpiPen Jr® as treatment options for patients at risk for anaphylaxis. Lastly, strategies to manage the risk of anaphylaxis in the community will be discussed.

Shashi Kumar MD

In accordance with the PhRMA code on interactions with healthcare professionals, attendance at this educational program is limited to healthcare professionals. Accordingly, attendance by spouses and guests is not appropriate and associated expenses will not be reimbursed.